top of page
09/2019 Lab for Synthetic Immunity opened at Dana-Farber Cancer Institute and Harvard Medical School
07/2020 Our work on developing cancer-targeting gene circuit to treat pediatric high-grade glioma is supported by the St. Baldrick's Foundation
07/2020 Our work on utilizing synthetic gene circuit to treat ovarian cancer is supported by the Cancer Research Institute
03/2021 Our work on utilizing a Convolutional Neural Network based approach for exploring cancer sensor design space is supported by Amazon AWS AI Research Award
08/2022 Our work on developing Generative Adversarial Networks to create cancer sensors is supported by the Harvard Medical School Inaugural Bisconti Fund for AI-Focused Research.
06/2023 Our works on developing cancer-targeting gene circuits to treat ovarian cancer, prostate cancer, and breast cancer are supported by the Department of Defense.
08/2023 Our work on developing cancer-targeting gene circuits to treat melanoma is supported by the Harrington Discovery Institute.
01/2024 Our work on developing exhaustion-resistant CAR-T cells is supported by the Parker Institute of Cancer Immunotherapy.
03/2024 Our work on utilizing de novo designed luciferase to monitor immune cell states for cellular therapy is supported by the Chan Zuckerberg Biohub.
bottom of page